Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS
· Delayed Price · Currency is USD
0.0950
-0.0031 (-3.16%)
Apr 1, 2025, 3:57 PM EST
PVCT Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 0.31 | 0.08 | 0.02 | 0.68 | 0.1 | Upgrade
|
| Cash & Short-Term Investments | 0.31 | 0.08 | 0.02 | 0.68 | 0.1 | Upgrade
|
| Cash Growth | 301.49% | 254.44% | -96.84% | 602.43% | -83.54% | Upgrade
|
| Accounts Receivable | - | 0 | 0 | - | - | Upgrade
|
| Other Receivables | - | - | - | 0.01 | 0 | Upgrade
|
| Receivables | - | 0 | 0 | 0.01 | 0 | Upgrade
|
| Prepaid Expenses | 0.49 | 0.34 | 0.47 | 0.33 | 0.32 | Upgrade
|
| Restricted Cash | 0.18 | 0.95 | 1.41 | 2.42 | - | Upgrade
|
| Total Current Assets | 0.98 | 1.36 | 1.9 | 3.44 | 0.42 | Upgrade
|
| Property, Plant & Equipment | 0.03 | 0.08 | 0.14 | 0.07 | 0.17 | Upgrade
|
| Total Assets | 1.01 | 1.45 | 2.04 | 3.51 | 0.59 | Upgrade
|
| Accounts Payable | 1.11 | 1.68 | 2.09 | 1.29 | 0.96 | Upgrade
|
| Accrued Expenses | 2.35 | 3.39 | 2.48 | 2.02 | 6.04 | Upgrade
|
| Short-Term Debt | 0.21 | 0.28 | 0.24 | 0.24 | 0.21 | Upgrade
|
| Current Portion of Long-Term Debt | 2.95 | 2.68 | 1.83 | 1.46 | 23.42 | Upgrade
|
| Current Portion of Leases | 0.03 | 0.05 | 0.04 | 0.05 | 0.08 | Upgrade
|
| Current Unearned Revenue | 0.34 | 0.95 | 1.51 | 2.5 | - | Upgrade
|
| Other Current Liabilities | - | - | - | 0.15 | - | Upgrade
|
| Total Current Liabilities | 6.98 | 9.02 | 8.19 | 7.7 | 30.71 | Upgrade
|
| Long-Term Debt | - | - | - | - | 0.04 | Upgrade
|
| Long-Term Leases | - | 0.03 | 0.07 | - | 0.04 | Upgrade
|
| Total Liabilities | 6.98 | 9.04 | 8.27 | 7.7 | 30.8 | Upgrade
|
| Common Stock | 0.42 | 0.42 | 0.42 | 0.42 | 0.4 | Upgrade
|
| Additional Paid-In Capital | 251.09 | 244.71 | 242.95 | 241.44 | 209.92 | Upgrade
|
| Retained Earnings | -257.42 | -252.69 | -249.59 | -246.03 | -240.49 | Upgrade
|
| Comprehensive Income & Other | -0.06 | -0.06 | -0.04 | -0.03 | -0.03 | Upgrade
|
| Total Common Equity | -5.97 | -7.62 | -6.25 | -4.21 | -30.21 | Upgrade
|
| Minority Interest | -0.01 | - | - | - | - | Upgrade
|
| Shareholders' Equity | -5.97 | -7.59 | -6.23 | -4.19 | -30.21 | Upgrade
|
| Total Liabilities & Equity | 1.01 | 1.45 | 2.04 | 3.51 | 0.59 | Upgrade
|
| Total Debt | 3.18 | 3.03 | 2.18 | 1.74 | 23.8 | Upgrade
|
| Net Cash (Debt) | -2.88 | -2.95 | -2.16 | -1.06 | -23.7 | Upgrade
|
| Net Cash Per Share | -0.01 | -0.01 | -0.01 | -0.00 | -0.06 | Upgrade
|
| Filing Date Shares Outstanding | 420.28 | 419.52 | 419.5 | 419.45 | 403.56 | Upgrade
|
| Total Common Shares Outstanding | 419.52 | 419.52 | 419.5 | 419.45 | 398.81 | Upgrade
|
| Working Capital | -6 | -7.65 | -6.29 | -4.26 | -30.29 | Upgrade
|
| Book Value Per Share | -0.01 | -0.02 | -0.01 | -0.01 | -0.08 | Upgrade
|
| Tangible Book Value | -5.97 | -7.62 | -6.25 | -4.21 | -30.21 | Upgrade
|
| Tangible Book Value Per Share | -0.01 | -0.02 | -0.01 | -0.01 | -0.08 | Upgrade
|
| Machinery | - | 0.12 | 0.12 | 0.12 | 0.12 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.